Drug
Chf6001
Chf6001: highest development phase Phase 1, developed by Chiesi Farmaceutici. 2 trial records tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Chiesi Farmaceutici
Trials
| Drug | Phase | Indication |
|---|---|---|
| CHF6001 NCT04756960 | Phase 1 | Chronic Obstructive Pulmonary Disease (COPD) |
| CHF6001 NCT05373953 | Phase 1 | Chronic Obstructive Pulmonary Disease |
Latest
No recent events.
Follow Chf6001 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.